Pfizer Corporation

Pfizer Products Inc.

Kim Thomas Hall

David Morris Gethin

Denis Billen

Nathan Anthony Logan Chubb

Lee Richard Roberts

Nigel Derek Arthur Walshe

Douglas James Critcher

Jessica Boyle

Graham Michael Kyne

Nathan Anthony Chubb

Nigel Derek Walshe

This invention relates to a combination product comprising a compound of formula I wherein X, R, R, R, R, R, R, Rand Rare as described herein, and one or more further biologically active compounds as described herein, particularly anti-parasitic agents.

Substituted arylpyrazoles

This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which the cyclopropyl ring is substituted at the angular position, and pharmaceutically acceptable salts and solvates thereof, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.

This invention relates to a combination product comprising a range of 1-aryl-4 -cyclopropylpyrazoles in which there is at least one fluorine attached to the cyclopropyl ring, and one o more further therapeutic agents, particularly anti-parasitic agents.

This invention relates to a range of 1-aryl-4-cyclopropylpyrazoles in which there is at least one fluorine attached to the cyclopropyl ring, to compositions comprising such compounds, processes to their synthesis and their use as parasiticides.

Growing community of inventors

Sandwich, United Kingdom

Kim Thomas Hall